As global health leaders convened at the United Nations in New York last month, a notable shift in the landscape of international aid emerged, driven by a potential influx of philanthropic funding from the artificial intelligence (A.I.) sector. This development comes amid declining government contributions, particularly from the United States, leaving many organizations scrambling to position themselves to receive what some anticipate could be a transformative wave of capital.
The source of this new funding is the anticipated initial public offerings (IPOs) of several major A.I. companies, expected to begin as soon as next month. These IPOs could channel tens of billions of dollars into charitable causes, including global health, through foundations and gift pledges from a new generation of ultrawealthy tech entrepreneurs who have shown a keen interest in health initiatives.
Industry insiders describe the current environment as a “gold rush,” with numerous international health organizations engaging in private discussions about how they would deploy significant new investments, ranging from $100 million projects to multi-billion-dollar funding. This emerging philanthropic model, sometimes called the “third wave of philanthropy,” could rival or even surpass traditional government aid from wealthy nations.
The influx could bring a tech-driven, impact-focused approach to global health, emphasizing measurable outcomes, accelerated innovation, and a rigorous assessment of effectiveness. However, experts caution that this mindset may not easily align with the complexities of health systems in low-income countries, which require long-term, multifaceted support and local sovereignty to thrive.
Dr. Neil Buddy Shah, CEO of the Clinton Health Access Initiative, highlighted the potential for meaningful impact, noting that these funds are “relentlessly focused” on driving measurable improvements in health outcomes. Yet concerns remain about the potential unintended consequences of this shift, including the risk that governments might further reduce their own contributions, assuming the private sector will fill the gap.
A prominent upcoming test case involves a proposed commitment of $2 billion to $3 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria. This sizable donation, brokered through GiveWell, a charity evaluator favored by “effective altruism” donors, would focus on malaria interventions in the hardest-hit regions. This proposal would grant donors considerable influence over program decisions, marking a departure from traditional Global Fund governance and raising questions about donor control versus country ownership.
The new philanthropists, many influenced by effective altruism—a philosophy emphasizing data-driven, cost-effective interventions—often express skepticism toward established aid institutions, labeling them as inefficient or outdated. Some in the tech philanthropy community refer to legacy organizations like the Bill & Melinda Gates Foundation as “TradPhil.” Yet figures such as Wendy Schmidt, who co-founded a global health charity with her husband Eric Schmidt, acknowledge the complexity of development work and emphasize the importance of collaboration with experienced practitioners on the ground.
While some new donors initially approached global health challenges with a startup mentality—favoring rapid disruption and innovation—there is a growing recognition that large-scale health delivery, especially in fragile environments, demands nuanced, context-specific strategies. Advocates like Alexander Berger of Coefficient Giving recommend cooperation with established institutions such as the Global Fund and Gavi to avoid fragmentation and preserve efficacy.
As this new philanthropic surge unfolds, experts warn of risks alongside opportunities. The preference for easily measured, discrete interventions may overshadow the critical but less quantifiable need to strengthen primary health care systems. Dr. Shah urges donors to broaden their understanding of “effectiveness” to include systemic health improvements that may not yield immediate metrics but are essential for sustainable progress.
Despite these challenges, voices within the new philanthropic community, including Jacob Trefethen of the OpenAI Foundation, express cautious optimism that the infusion of A.I.-derived wealth could help build a more equitable and sustainable future for global health. This transformation, they acknowledge, will require learning and adaptation but holds the promise of significantly advancing efforts to improve the lives of some of the world’s most vulnerable populations.